SAL Scientific extend service portfolio to include hybridoma characterisation, optimisation and monoclonal antibody production

SAL Scientific are excited to announce the extension of their cell biology service offering to include a range of services focused on monoclonal antibody production “We are now offering our customers the opportunity to benefit from our expertise and infrastructure to screen their hybridomas to identify cell lines displaying heterogeneity, to reclone unstable lines selecting for high expressors, and cell expansion and purification of up to 100 mg of antibody” said SAL Scientific co-founder Dr Steve Game.

For more information, please visit here